The Asian Pacific TAVR Multicenter Registry (AP TAVR)

Michael Kang-Yin Lee, MD

Status: Unknown

Conditions: Aortic Valve Stenosis

Treatments: Device: Transcatheter aortic valve Replacement

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02195102

AMCCV 2013-12

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve Replacement (TAVR) in the Asian Pacific population

Enrollment: 2,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.
• The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Trial design

2,000 participants in 1 patient group

transcatheter aortic valve Replacement

Description:

Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.

Treatment:

Device: Transcatheter aortic valve Replacement